Since 2013 deputy director of the institute. Diploma in Biochemistry at Eberhard Karls University and PhD in Cell Biology and Embriology at Max Planck Institute, both in Tübingen.
After completing his doctorate in cell biology and embriology in 1994, Dr. Thomas Joos worked for another four years as a scientist at the Max Planck Institute before moving to the NMI and becoming a group leader in biochemistry. His research interests include biomarker technologies, the development of protein immunoassays and the field of personalized medicine.
Selected publications
- M.F. Templin, D. Stoll, M. Schrenk, P.C. Traub, C.F. Vohringer, and T.O. Joos, Protein microarray technology. Trends Biotechnol 20 (2002) 160-6.
- Joos TO, Berger H. The long and difficult road to the diagnostic market: protein microarrays. Drug Discov Today. 2006 Nov;11(21-22):959-61. PMID: 17055403 DOI: 10.1016/j.drudis.2006.09.014
- Poetz O, Henzler T, Hartmann M, Kazmaier C, Templin MF, Herget T, Joos TO. Sequential multiplex analyte capturing for phosphoprotein profiling. Mol Cell Proteomics. 2010 Nov;9(11):2474-81. PMCID: PMC2984240
DOI: 10.1074/mcp.M110.002709
- Carcamo Yañez VA, Göpfert JC, Otto M, Tumani H, Peter A, Joos TO. Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay. High Throughput. 2017 Nov 16;6(4). PMCID: PMC5748597 DOI: 10.3390/ht6040018
- Poetz O, Dieze T, Hammer H, Weiß F, Sommersdorf C, Templin MF, Esdar C, Zimmermann A, Stevanovic S, Bedke J, Stenzl A, Joos TO. Peptide-Based Sandwich Immunoassay for the Quantification of the Membrane Transporter Multidrug Resistance Protein 1. Anal Chem. 2018 May 1;90(9):5788-5794. PMID: 29570278; DOI: 10.1021/acs.analchem.8b00152
eRA COMMONS USER NAME: THOMASJOOS
ORCID: 0000-0003-3042-81741